Drugs Approved for Non-Small Cell Lung Cancer
- Abraxane (Paclitaxel Albumin-stabilized Nanoparticle Formulation)
- Adagrasib
- Afatinib Dimaleate
- Afinitor (Everolimus)
- Afinitor Disperz (Everolimus)
- Alecensa (Alectinib)
- Alectinib
- Alimta (Pemetrexed Disodium)
- Alunbrig (Brigatinib)
- Alymsys (Bevacizumab)
- Amivantamab-vmjw
- Atezolizumab
- Atezolizumab and Hyaluronidase-tqjs
- Augtyro (Repotrectinib)
- Avastin (Bevacizumab)
- Bevacizumab
- Binimetinib
- Bizengri (Zenocutuzumab-zbco)
- Braftovi (Encorafenib)
- Brigatinib
- Capmatinib Hydrochloride
- Cemiplimab-rwlc
- Ceritinib
- Crizotinib
- Cyramza (Ramucirumab)
- Dabrafenib Mesylate
- Dacomitinib
- Docetaxel
- Doxorubicin Hydrochloride
- Durvalumab
- Encorafenib
- Enhertu (Fam-Trastuzumab Deruxtecan-nxki)
- Ensacove (Ensartinib Hydrochloride)
- Ensartinib Hydrochloride
- Entrectinib
- Erlotinib Hydrochloride
- Everolimus
- Fam-Trastuzumab Deruxtecan-nxki
- Gavreto (Pralsetinib)
- Gefitinib
- Gilotrif (Afatinib Dimaleate)
- Gemcitabine Hydrochloride
- Gemzar (Gemcitabine Hydrochloride)
- Imfinzi (Durvalumab)
- Imjudo (Tremelimumab-actl)
- Infugem (Gemcitabine Hydrochloride)
- Ipilimumab
- Iressa (Gefitinib)
- Keytruda (Pembrolizumab)
- Krazati (Adagrasib)
- Lazcluze (Lazertinib Mesylate Hydrate)
- Lazertinib Mesylate Hydrate
- Libtayo (Cemiplimab-rwlc)
- Lorbrena (Lorlatinib)
- Lorlatinib
- Lumakras (Sotorasib)
- Mekinist (Trametinib Dimethyl Sulfoxide)
- Mektovi (Binimetinib)
- Methotrexate Sodium
- Mvasi (Bevacizumab)
- Necitumumab
- Nivolumab
- Nivolumab and Hyaluronidase-nvhy
- Opdivo (Nivolumab)
- Opdivo Qvantig (Nivolumab and Hyaluronidase-nvhy)
- Osimertinib Mesylate
- Paclitaxel
- Paclitaxel Albumin-stabilized Nanoparticle Formulation
- Pembrolizumab
- Pemetrexed Disodium
- Portrazza (Necitumumab)
- Pralsetinib
- Ramucirumab
- Repotrectinib
- Retevmo (Selpercatinib)
- Rozlytrek (Entrectinib)
- Rybrevant (Amivantamab-vmjw)
- Selpercatinib
- Sotorasib
- Tabrecta (Capmatinib Hydrochloride)
- Tafinlar (Dabrafenib Mesylate)
- Tagrisso (Osimertinib Mesylate)
- Tarceva (Erlotinib Hydrochloride)
- Taxotere (Docetaxel)
- Tecentriq (Atezolizumab)
- Tecentriq Hybreza (Atezolizumab and Hyaluronidase-tqjs)
- Tepmetko (Tepotinib Hydrochloride)
- Tepotinib Hydrochloride
- Trametinib Dimethyl Sulfoxide
- Tremelimumab-actl
- Vizimpro (Dacomitinib)
- Vinorelbine Tartrate
- Xalkori (Crizotinib)
- Yervoy (Ipilimumab)
- Zenocutuzumab-zbco
- Zirabev (Bevacizumab)
- Zykadia (Ceritinib)
Drug Combinations Used to Treat Non-Small Cell Lung Cancer
Drugs Approved for Small Cell Lung Cancer
- Afinitor (Everolimus)
- Atezolizumab
- Atezolizumab and Hyaluronidase-tqjs
- Doxorubicin Hydrochloride
- Durvalumab
- Etopophos (Etoposide Phosphate)
- Etoposide
- Etoposide Phosphate
- Everolimus
- Hycamtin (Topotecan Hydrochloride)
- Imdelltra (Tarlatamab-dlle)
- Imfinzi (Durvalumab)
- Lurbinectedin
- Methotrexate Sodium
- Nivolumab
- Opdivo (Nivolumab)
- Tarlatamab-dlle
- Tecentriq (Atezolizumab)
- Tecentriq Hybreza (Atezolizumab and Hyaluronidase-tqjs)
- Topotecan Hydrochloride
- Zepzelca (Lurbinectedin)